Crossmark

Safety and clinical impact of FEES – results of the FEES-registry

Crossref DOI link: https://doi.org/10.1186/s42466-019-0021-5

Published Online: 2019-04-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dziewas, Rainer https://orcid.org/0000-0003-1592-8461
auf dem Brinke, Matthias

Birkmann, Ulrich

Bräuer, Götz

Busch, Kolja

Cerra, Franziska

Damm-Lunau, Renate

Dunkel, Juliane

Fellgiebel, Amelie

Garms, Elisabeth

Glahn, Jörg

Hagen, Sandra

Held, Sophie

Helfer, Christine

Hiller, Mirko

Horn-Schenk, Christina

Kley, Christoph

Lange, Nikolaus

Lapa, Sriramya

Ledl, Christian

Lindner-Pfleghar, Beate

Mertl-Rötzer, Marion

Müller, Madeleine

Neugebauer, Hermann

Özsucu, Duygu

Ohms, Michael

Perniß, Markus

Pfeilschifter, Waltraud

Plass, Tanja

Roth, Christian

Roukens, Robin

Schmidt-Wilcke, Tobias

Schumann, Beate

Schwarze, Julia

Schweikert, Kathi

Stege, Holger

Theuerkauf, Dirk

Thomas, Randall S.

Vahle, Ulrich

Voigt, Nancy

Weber, Hermann

Werner, Cornelius J.

Wirth, Rainer

Wittich, Ingo

Woldag, Hartwig

Warnecke, Tobias
License Information

Text and Data Mining valid from 2019-04-26
More Information

Article History

Received: 15 November 2018

Accepted: 10 January 2019

First Online: 26 April 2019

Ethics approval and consent to participate

: The study protocol was originally approved by the ethics committee of the Westfälische Wilhelms University Münster (2014–370-f-S) on August 19th 2014 and was also approved by all other involved ethics committees. All patients or their legal representative provided written informed consent.

: Not applicable.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below